rs536639583

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_000523.4(HOXD13):​c.32G>C​(p.Gly11Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0005 in 1,329,670 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00086 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00045 ( 4 hom. )

Consequence

HOXD13
NM_000523.4 missense

Scores

2
4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:2

Conservation

PhyloP100: 0.282

Publications

11 publications found
Variant links:
Genes affected
HOXD13 (HGNC:5136): (homeobox D13) This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located in a cluster on chromosome 2. Deletions that remove the entire HOXD gene cluster or the 5' end of this cluster have been associated with severe limb and genital abnormalities. Mutations in this particular gene cause synpolydactyly. [provided by RefSeq, Jul 2008]
HOXD13 Gene-Disease associations (from GenCC):
  • brachydactyly-syndactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
  • synpolydactyly type 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • brachydactyly type E
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • syndactyly type 5
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.118177116).
BP6
Variant 2-176092922-G-C is Benign according to our data. Variant chr2-176092922-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225651.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000856 (130/151790) while in subpopulation EAS AF = 0.022 (113/5136). AF 95% confidence interval is 0.0187. There are 1 homozygotes in GnomAd4. There are 67 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 130 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HOXD13NM_000523.4 linkc.32G>C p.Gly11Ala missense_variant Exon 1 of 2 ENST00000392539.4 NP_000514.2 P35453
HOXD13XM_011511068.3 linkc.725-1558G>C intron_variant Intron 1 of 1 XP_011509370.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HOXD13ENST00000392539.4 linkc.32G>C p.Gly11Ala missense_variant Exon 1 of 2 1 NM_000523.4 ENSP00000376322.3 P35453

Frequencies

GnomAD3 genomes
AF:
0.000857
AC:
130
AN:
151682
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0219
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000185
AC:
7
AN:
37778
AF XY:
0.000299
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00400
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000454
AC:
535
AN:
1177880
Hom.:
4
Cov.:
30
AF XY:
0.000438
AC XY:
252
AN XY:
575020
show subpopulations
African (AFR)
AF:
0.0000429
AC:
1
AN:
23296
American (AMR)
AF:
0.00
AC:
0
AN:
13218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17532
East Asian (EAS)
AF:
0.0167
AC:
428
AN:
25650
South Asian (SAS)
AF:
0.000693
AC:
32
AN:
46166
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26040
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3380
European-Non Finnish (NFE)
AF:
0.00000923
AC:
9
AN:
975526
Other (OTH)
AF:
0.00138
AC:
65
AN:
47072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000856
AC:
130
AN:
151790
Hom.:
1
Cov.:
33
AF XY:
0.000903
AC XY:
67
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41516
American (AMR)
AF:
0.000263
AC:
4
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0220
AC:
113
AN:
5136
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67890
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000277
Hom.:
0
Bravo
AF:
0.00106
ExAC
AF:
0.000528
AC:
8
Asia WGS
AF:
0.00499
AC:
17
AN:
3418

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:2
Mar 15, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The G11A variant has been published previously in association with a synpolydactyly phenotype; the homozygous proband was more severely affected than the heterozygous mother, but the father's phenotype was not provided (Brison et al., 2012). However, the variant has also been observed in the homozygous state at GeneDx in an individual whose phenotype did not match a HOXD13 presentation. The variant is observed in 3/1714 (0.175%) alleles from individuals of South Asian background in the ExAC dataset (Lek et al., 2016). G11A is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Functional studies have shown that G11A has no effect on DNA binding, transactivation, or localization; however, it speeds protein degradation and led to skeletal abnormalities in chick embryos (Brison et al., 2012). In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Apr 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HOXD13: PP3, BS1 -

Synpolydactyly type 1 Pathogenic:1
Jul 20, 2018
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Brachydactyly type D;C1862102:Brachydactyly type E1 Uncertain:1
Oct 20, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.060
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.59
T
M_CAP
Pathogenic
0.85
D
MetaRNN
Benign
0.12
T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
0.69
N
PhyloP100
0.28
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.88
N
REVEL
Uncertain
0.62
Sift
Benign
0.12
T
Sift4G
Benign
0.17
T
Polyphen
0.95
P
Vest4
0.71
MutPred
0.66
Gain of helix (P = 0.0034);
MVP
0.95
ClinPred
0.16
T
GERP RS
2.3
PromoterAI
0.046
Neutral
Varity_R
0.13
gMVP
0.39
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs536639583; hg19: chr2-176957650; API